Metagenomi Therapeutics (MGX) Non Operating Income (2023 - 2026)
Metagenomi Therapeutics (MGX) reported Non Operating Income of $1.29 million for Q2 2026, up 15.0% from $1.12 million a year earlier but down 16.1% from the prior quarter.
Powered by 
Analysis
Metagenomi Therapeutics (MGX) Non Operating Income (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Metagenomi Therapeutics' Non Operating Income came in at $6.91 million, up 354.0% year-over-year; for FY2025, it came in at $8.09 million, up 51.7% from FY2024.
- By year, Non Operating Income came in at $5.33 million in FY2024 (-70.8%) and $18.26 million in FY2023.
- Five-year quarterly Non Operating Income spans a low of -$3.98 million in Q4 2024 and a high of $6.85 million in Q2 2023.
- Year over year, Non Operating Income gained in two of the last six quarters, with an average decline of 23.7%.
- The high point for year-over-year Non Operating Income in five years was Q3 2025 (growth of 47.1%); the low point was Q2 2025 (a decline of 71.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.54 million (Q1 2026), $1.87 million (Q4 2025) and $2.21 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Metagenomi Therapeutics | 40.04 Mn | 40.04 Mn | - | 1.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.29 Mn |
| Mar 31, 2026 | 1.54 Mn |
| Dec 31, 2025 | 1.87 Mn |
| Sep 30, 2025 | 2.21 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 2.88 Mn |
| Dec 31, 2024 | -3.98 Mn |
| Sep 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 3.93 Mn |
| Mar 31, 2024 | 3.88 Mn |
| Dec 31, 2023 | 3.63 Mn |
| Sep 30, 2023 | 3.78 Mn |
| Jun 30, 2023 | 6.85 Mn |
| Mar 31, 2023 | 4.00 Mn |
API Access
Metagenomi Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=MGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "MGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=MGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();